Omega-3 carboxylic acids in severe hypertriglyceridemia: EVOLVE II study results

Erik S.G. Stroes,T.W.A. de Bruin,Michael Davidson,Hong Yang,Mats Kvarnström,Torbjörn Lundström

ATHEROSCLEROSIS（2016）

引用 1|浏览13

暂无评分

摘要

Objectives: Assess efficacy and safety of omega-3 carboxylic acids (Epanova ®) 2 g daily for lowering serum TG in severe hypertriglyceridemia (TG ≥5.65 mmol/L [≥500 mg/dL] and <28.25 mmol/L [2500 mg/dL] and a stratum of TG >10.0 mmol/L [>885 mg/dL].

查看译文

关键词

severe hypertriglyceridemia,carboxylic acids

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要